Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Cheung

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2012
HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120James M Kovacs, Joseph P Nkolola, Hanqin Peng, et al.
Vaccine|February 22, 2014
Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimerJoseph P Nkolola, Ann Cheung, James R Perry, et al.
Med (New York, N.Y.)|April 14, 2023
An optimized IL-12-Fc expands its therapeutic window, achieving strong activity against mouse tumors at tolerable drug dosesEva Gutierrez, Mitchell Bigelow, Colin LaCroix, et al.
BMC Pediatrics|November 11, 2022
Utility of illness symptoms for predicting COVID-19 infections in childrenGeena Y Zhou, Nicole Y Penwill, Grace Cheng, et al.
Nature Genetics|April 1, 2008
Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colonKevin M Haigis, Krystle R Kendall, Yufang Wang, et al.
Journal of Virology|June 27, 2014
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimerJoseph P Nkolola, Christine A Bricault, Ann Cheung, et al.
Journal of Virology|December 26, 2014
A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual componentChristine A Bricault, James M Kovacs, Joseph P Nkolola, et al.
The Journal of Infectious Diseases|November 6, 2012
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001)Dan H Barouch, Jinyan Liu, Lauren Peter, et al.
The Journal of Infectious Diseases|November 6, 2012
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2012
HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120James M Kovacs, Joseph P Nkolola, Hanqin Peng, et al.
Vaccine|February 22, 2014
Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimerJoseph P Nkolola, Ann Cheung, James R Perry, et al.
Med (New York, N.Y.)|April 14, 2023
An optimized IL-12-Fc expands its therapeutic window, achieving strong activity against mouse tumors at tolerable drug dosesEva Gutierrez, Mitchell Bigelow, Colin LaCroix, et al.
BMC Pediatrics|November 11, 2022
Utility of illness symptoms for predicting COVID-19 infections in childrenGeena Y Zhou, Nicole Y Penwill, Grace Cheng, et al.
Nature Genetics|April 1, 2008
Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colonKevin M Haigis, Krystle R Kendall, Yufang Wang, et al.
Journal of Virology|June 27, 2014
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimerJoseph P Nkolola, Christine A Bricault, Ann Cheung, et al.
Journal of Virology|December 26, 2014
A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual componentChristine A Bricault, James M Kovacs, Joseph P Nkolola, et al.
The Journal of Infectious Diseases|November 6, 2012
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001)Dan H Barouch, Jinyan Liu, Lauren Peter, et al.
The Journal of Infectious Diseases|November 6, 2012
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
Pageof 2